Registry Measuring the Impact of Adding RNA Expression Testing on Referral Decisions in Early Stage Lung Cancer Patients and Assessing the Disease-free Survival With Long-term Follow-up
- Status
- TERMINATED
- Phase
- N/A
Clinical Trials Related to Lung Adenocarcinoma
Related studies linked through entity extraction aliases.
A Study Examining Maintenance Bevacizumab (Avastin®) Monotherapy in Participants With Advanced Lung Adenocarcinoma
- Status
- COMPLETED
- Phase
- N/A
Comparison of cVATS Segmentectomy Versus Lobectomy for Lung Adenocarcinoma in Situ and With Microinvasion
- Status
- UNKNOWN
- Phase
- PHASE3
Prognostic Value of the Marker P63 in Adenocarcinoma of Lung, Breast, and Pancreas
- Status
- UNKNOWN
- Phase
- N/A
Sirolimus and Auranofin in Treating Patients With Advanced or Recurrent Non-Small Cell Lung Cancer or Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Erlotinib Plus Pemetrexed to Treat Lung Adenocarcinoma With Brain Metastases
- Status
- COMPLETED
- Phase
- PHASE2
Study of Metformin Plus Paclitaxel/Carboplatin/Bevacizumab in Patients With Adenocarcinoma.
- Status
- TERMINATED
- Phase
- PHASE2
Study of Early-stage Lung Adenocarcinoma for Early Detection and Effective Treatment Strategy
- Status
- UNKNOWN
- Phase
- N/A
Veliparib With or Without Radiation Therapy, Carboplatin, and Paclitaxel in Patients With Stage III Non-small Cell Lung Cancer That Cannot Be Removed by Surgery
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
MK2206 and Erlotinib Hydrochloride in Treating Patients With Advanced Non-Small Cell Lung Cancer Who Have Progressed After Previous Response to Erlotinib Hydrochloride Therapy
- Status
- COMPLETED
- Phase
- PHASE2
Expression of AMP-activated Protein Kinase (AMPK) Protein in Lung Adenocarcinoma
- Status
- UNKNOWN
- Phase
- N/A
Expression of Optic Atrophy Type 1 (OPA1) Protein in Lung Adenocarcinoma
- Status
- UNKNOWN
- Phase
- N/A
Paclitaxel, Carboplatin, and Bevacizumab With or Without Cixutumumab in Treating Patients With Stage IV or Recurrent Non-small Cell Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Pemetrexed Disodium With or Without Erlotinib Hydrochloride in Treating Patients With Stage IIIB-IV or Recurrent Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Cetuximab in Patients With Lung Adenocarcinoma Receiving Erlotinib That Have Developed "Acquired Resistance" to Erlotinib
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Combination Chemotherapy, Radiation Therapy, and Bevacizumab in Treating Patients With Newly Diagnosed Stage III Non-small Cell Lung Cancer That Cannot Be Removed by Surgery
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Erlotinib Hydrochloride With or Without Carboplatin and Paclitaxel in Treating Patients With Stage III-IV Non-small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2